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ABSTRACT
BACKGROUND AND PURPOSE: Glutathione is an important antioxidant in the human brain and therefore of interest in neurodegenera-
tive disorders. The purpose of this studywas to investigate the feasibility ofmeasuring glutathione in healthy nonsedated children by using
the 1H Mescher-Garwood point-resolved spectroscopy (MEGA-PRESS) sequence at 3T and to compare glutathione levels between the
medial parietal gray matter and the cerebellum.
MATERIALS AND METHODS: Glutathione was measured using MEGA-PRESS MRS (TR 1.8 seconds, TE 131 ms) in the parietal gray matter
(35 25 20mm3) of 6 healthy children (10.0 2.4 years of age; range, 7–14 years; 3males) and in the cerebellumof 11 healthy children (12.0 2.7
yearsof age; range, 7–16 years; 6males). Apostprocessingpipelinewasdeveloped toaccount for frequencyandphasevariations in theeditedON
and nonedited OFF spectra. Metabolites were quantiﬁed with LCModel and reported both as ratios and water-scaled values. Glutathione was
quantiﬁed in the ON-OFF spectra, whereas total NAA, total Cho, total Cr, mIns, Glx, and taurine were quantiﬁed in the OFF spectra.
RESULTS: We found signiﬁcantly higher glutathione, total Cho, total Cr, mIns, and taurine in the cerebellum (P .01). Glx and total NAA
were signiﬁcantly higher in the parietal gray matter (P .01). There was no signiﬁcant difference in glutathione/total Cr (P .93) between
parietal gray matter and cerebellum.
CONCLUSIONS: We demonstrated that glutathione measurement in nonsedated children is feasible. We found signiﬁcantly higher
glutathione in the cerebellum compared with the parietal gray matter. Metabolite differences between the parietal gray matter and
cerebellum agree with published MRS data in adults.
ABBREVIATIONS: GSH glutathione; MEGA-PRESSMescher-Garwood point-resolved spectroscopy; PGM parietal gray matter; Tau taurine; t- total
Glutathione (GSH) is an important antioxidant in the humanbrain1,2 and has been shown to be altered in a number of
pathologies.3-7 Measuring GSH is of interest in neurodegenera-
tive disorders8 and may be a potential mechanistic biomarker for
oxidative stress–related diseases and the efficacy of antioxidative
treatments. Our specific interest is the quantification of GSH in
the brains of children affected by neurodegenerative diseases such
as ataxia telangiectasia, requiring a robust method to measure
GSH levels in nonsedated children.
GSH can, in principle, be measured in vivo with 1H-MRS.
However, due to the low concentration of GSH in the healthy
human brain and in particular its overlap with higher concentra-
tion metabolites, quantification of GSH at 3T with conventional
MRS sequences is controversial.9-11 Spectral editing allows the
removal of overlapping resonances for a direct and robust quan-
tification of GSH.12-14 While spectral editing can be used to spe-
cifically measure GSH, it is more susceptible to subject motion
than conventional single-voxel MRS sequences due to longer scan
times and because spectral editing is a subtraction technique that
relies on consistent data acquisition.
Few studies have reported in vivo GSH values in healthy chil-
dren,15,16 and, to our knowledge, there is no study that specifically
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measured GSH in children using spectral editing techniques or
that reported GSH in the cerebellum. Therefore, the goal of this
study was to investigate the feasibility of measuring GSH in
healthy nonsedated children with the Mescher-Garwood point-
resolved spectroscopy (MEGA-PRESS)13,17 sequence and to com-
pare GSH levels obtained in the medial parietal gray matter
(PGM) with those measured in the cerebellum. To minimize sub-
traction errors caused by phase and frequency variations, we
adapted a MEGA-PRESS postprocessing technique published by
An et al17 and modified it to work with our data.
MATERIALS AND METHODS
Subjects
Healthy children were recruited as part of an ongoing study, ap-
proved by the UK National Research Ethics Service East Mid-
lands–Derby Committee (Reference 14/EM/1175). Informed
consent was obtained from parents or guardians of participants.
MRS data in the PGM were acquired in 6 children (10.0  2.4
years of age; range, 7–14 years; 3 males). MR spectroscopic data in
the cerebellum were acquired in 11 children (12.0 2.7 years of
age; range, 7–16 years; 6 males). There was no significant differ-
ence in age between the 2 groups (t test, P .14). Structural MRI
was checked by a neuroradiologist (R.A.D.) to ensure that children
were neuroradiologically healthy.
Data Acquisition
Data were acquired on a 3T MR scanner (Discovery MR750; GE
Healthcare, Milwaukee, Wisconsin) equipped with a 32-channel
head coil, without sedation. In addition to standard pediatric MRI
preparation, younger participants were shown an animation to
help prepare them for the MRI,18 and participants could watch
videos on an MRI– compatible monitor during the scan to im-
prove tolerance. The MRI protocol included a 3D fast-spoiled
gradient recalled T1-weighted structural MRI with 1-mm isotro-
pic resolution for MRS planning (TR 8.15 ms, TE 3.172 ms,
TI 900 ms, FOV 256 256 156 mm). Single-voxel MEGA-
PRESS GSH editing was performed using TR 2 seconds, TE
131 ms, and 128 ON and 128 OFF acquisitions. Spectral editing
was achieved with sinc-weighted Gaussian pulses with a pulse
length of 20 ms (bandwidth, 64 Hz) applied at 7.5 ppm (OFF) and
4.54 ppm (ON) for editing GSH.13,17 A nonedited, water-unsup-
pressed reference scan of 16 averages was acquired at identical
acquisition parameters. MRS voxel sizes were 35 25 20 mm in
the PGM and 50 22 22 mm in the cerebellum. Typical voxel
locations are illustrated in Fig 1. Total acquisition time for
MEGA-PRESS MRS was 9 minutes 30 seconds.
MRS Processing
MEGA-PRESS data were processed off-line with Matlab (Math-
Works, Natick, Massachusetts). The workflow steps A–H are il-
lustrated in On-line Fig 1. The phase angles between the 32 coil
elements were calculated from the average unsuppressed water
signal (A). All ON and OFF spectra were subsequently phased
using the water phase angles and coil-combined by using the max-
imum peak height of the unsuppressed water signal as weighting
factors (B). The resulting coil-combined 128 ON and 128 OFF
spectra were potentially out of phase relative to each other due to
subject motion and frequency drift. To correct for this, we phased
individual ON and OFF spectra by maximizing the correlation of
the NAA peak between the real and absolute part of the spectrum in
the range of 1.87 and 2.21 ppm (C). Next, a reference ON spectrum
for phase and frequency correction was created, like that described by
An et al17 by pair-wise aligning the 128 ON spectra in the spectral
range of 1.3 and 3.3 ppm and iterative pair-wise averaging of the
spectra with the smallest root mean square error (D). All 128 ON and
128 OFF spectra were subsequently aligned to this ON reference
spectrum by time domain phase and frequency correction using the
fminsearch function (https://de.mathworks.com/help/matlab/ref/
fminsearch.html) (E) in Matlab. For the alignment, the correlation
coefficient of the real part of the NAA peak (1.87–2.21 ppm) be-
tween the ON reference spectrum and the individual ON and OFF
spectra was maximized. The 128 aligned ON and OFF spectra
were then averaged to 1 ON and 1 OFF spectrum each (F). Indi-
vidual poor-quality ON and OFF spectra were detected by calcu-
lating the correlation coefficient of the NAA peak (1.87–2.21
ppm) between the 128 ON/OFF spectra and the averaged ON/
OFF spectrum, respectively (G). In our data, a correlation coeffi-
cient threshold of 0.8 (1 indicating perfect correlation) was used
to pair-wise exclude individual ON and OFF spectra. Finally, the
new ON and OFF average spectra were recalculated (H) and sub-
tracted to obtain the final edited ON-OFF spectrum.
Metabolite Quantiﬁcation
Unedited MEGA-PRESS OFF spectra were analyzed between 4
and 0.2 ppm with LCModel (Version 6.3-1H; http://www.lcmodel.
com/lcmodel.shtml)19 using a basis set simulated with TARQUIN
(http://tarquin.sourceforge.net/).20 The OFF spectra were used to
quantify total NAA (tNAA  NAA N-acetyl aspartylgluta-
mate), total Creatine (tCr  Cr  phosphocreatine), total
Choline (tCho  glycerophosphorylcholine  phosphoryl-
choline), mIns, Glx, and Taurine (Tau). The edited ON-OFF
MEGA-PRESS spectra were analyzed in the range of 3.6 – 0.2
ppm with LCModel, using a measured basis set from GSH and
NAA solutions. LCModel parameters for the ON-OFF analysis
are given in the On-line Appendix.
Metabolite values are reported as ratios to tCr and as water-
scaled values using the unsuppressed OFF water signal. For the
latter, corresponding structural T1WI was segmented via SPM
software (http://www.fil.ion.ucl.ac.uk/spm/software/spm12) into
gray matter, white matter, and CSF and aligned with the MRS vol-
ume with in-house software. Water-scaled metabolite values were
corrected for CSF contamination by dividing them by 1–CSF%. Be-
cause the complex anatomic structure in the cerebellum would not
allow an accurate separation of gray and white matter, we did not take
their differences in water content into account. T1 and T2 correction
was not performed; thus, water-scaled and CSF-corrected metabolite
values are reported as institutional units.
A 2-sample t test assuming unequal variances was used to de-
termine significant differences in metabolite values and ratios be-
tween the PGM and the cerebellum.
RESULTS
The proposed GSH processing gave robust results in all spectra.
On-line Fig 2 shows the edited ON-OFF spectra and correspond-
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ing GSH fits determined by LCModel for all subjects. An example
in On-line Fig 1 illustrates the correction for phase and frequency
shifts in a PGM spectrum acquired in an 11-year-old girl.
Figure 1 shows sample spectra from the PGM and cerebellum and
corresponding metabolite fits for two 7-year-old children. The OFF
spectra from the cerebellum show visible resonances between 3.3 and
3.5 ppm (see the arrow in Fig 1D). LCModel assigned these reso-
nances to taurine (around 3.4 ppm) and scyllo-inositol (around 3.34
ppm), but the fitted scyllo-inositol signals were too small for reliable
quantification in both the cerebellum (Cramer-Rao lower bounds,
21% 22%) and PGM (Cramer-Rao lower bounds, 33% 27%).
We therefore only report the apparent taurine signal for the cerebel-
lum (Cramer-Rao lower bounds, 9%1%) and PGM (Cramer-Rao
lower bounds, 14% 2%). However, the combined sum of Tau
scyllo-inositol showed the same trends as taurine using either water
scaling or ratios (results not shown).
We found significantly higher GSH in the cerebellum com-
pared with the PGM (P  .01). Additionally, we found higher
tCho (P .01), tCr (P .01), mIns (P .01), and Tau (P .01)
in the cerebellum, whereas NAA (P .01) and Glx (P .01) were
significantly higher in the PGM. Boxplots are shown in Fig 2.
Figure 3 shows the results of the metabolite ratios between the
PGM and cerebellum. There was no significant difference in GSH/
tCr (P  .93). However, tNAA/tCr (P  .01), tNAA/tCho (P 
.01), mIns/tCr (P .01), and Glx/tCr (P .01) were significantly
higher in the PGM. Both tCho/tCr (P  .01) and Tau/tCr (P 
.02) were lower in the PGM.
DISCUSSION
We demonstrate reliable detection of glutathione levels in the parietal
gray matter and cerebellum of nonsedated children using a dedicated
proton MRS protocol for acquisition and postprocessing. Postpro-
FIG 1. Examples of the MRS voxel placement in the PGM (A) and cerebellum (B) in two 7-year-old children. Corresponding OFF (C and D) and
ON-OFF (E and F) spectra are shown below. Individual metabolite spectra ﬁtted by LCModel are highlighted in different colors. D, The arrow
highlights visible resonances that are particularly large in the cerebellum and likely belong to taurine and scyllo-inositol. Residuals of the ﬁts
(black, upper row) and estimated LCModel baselines (black, lower row) are shown for each spectrum.
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cessing of GSH MEGA-PRESS MRS was challenging, mainly because
the editing pulse at 4.54 ppm also eliminates most of the residual
water signal in the ON spectrum; this feature makes it difficult to
precisely match its phase to the OFF spectrum. This difficulty can
lead to subtraction artifacts, which are most often visible around the
2-ppm area and could severely bias GSH quantification due to resid-
ual overlapping Cr signal at 3 ppm. We therefore adapted and mod-
ified a previously published postprocessing approach.17 Whereas An
et al17 focused on the complex spectral values from the Cr, Cho, and
NAA peaks for alignment of individual spectra, our processing was
simplified by focusing the alignment on the real part of the NAA and
omitting zero and first-order baseline ad-
justments. This was performed to reduce
the number of fitted parameters for a
more robust parameter determination in
our lower SNR spectra caused by a smaller
voxel size.
To the best of our knowledge, this is
the first study to compare GSH levels in
the cerebrum with those found in the cer-
ebellum in children. Few studies com-
pared GSH levels between the cerebellum
and the cerebrum in adults. In agreement
with our findings, Emir et al21 found
higher GSH and tCr in the vermis com-
pared with the occipital cortex and poste-
rior cingulate in healthy adults using a
short-echo STEAM sequence at 7T, albeit
without T1, T2, and CSF correction. An
extensive postmortem study in humans by
Tong et al22 showed no significant differ-
ence in GSH between the occipital and
cerebellar cortices in the 1- to 18-year age
group. A histologic study in mice by Kang
et al23 revealed slightly lower GSH in the
cerebellum compared with the cortex.
Previous studies reported higher Cho
and Cr levels in the cerebellum compared
with the cerebrum in healthy adults,24,25
in agreement with the results in our cohort
of children, whereas an MR spectroscopic
imaging study by Lecocq et al26 found only
reduced NAA in the cerebellum. Looking
at metabolite ratios, several studies found
lower tNAA/tCr in the cerebellum com-
pared with the cerebrum in children27 and
adults,28-30 in agreement with our find-
ings. Additionally, Goryawala et al31
showed lower Glx/tCr in the cerebellum
in adults, in agreement with our results in
children. Another noteworthy finding in
this study was higher apparent Tau/tCr
in the cerebellum compared with the PGM.
Taurine is particularly high in infants and
children in the cerebellar cortex.32,33 Ad-
ditionally, elevated taurine is characteristic
of medulloblastomas,34 mainly originat-
ing in the cerebellum of children.
A limitation of this study is the relatively small sample size and
the use of different subjects to scan the PGM and the cerebellum.
Scanning the PGM and cerebellum in each subject would have
allowed a pair-wise statistical analysis and likely reduced variabil-
ity. We were, however, limited by time constraints in the MRI
protocol due to the long acquisition time of GSH MEGA-PRESS
MRS. Additionally, the MRS voxel in the cerebellum was rela-
tively large, to ensure high-enough SNR for GSH quantification,
thus having a relatively heterogeneous tissue composition, in-
cluding the cerebellar gray matter (vermis and cortex) and the
underlying cerebellar white matter.
FIG 2. Boxplots showing the water-scaledmetabolite values in institutional units in the PGM and
cerebellum.
FIG 3. Boxplots showing the metabolite ratios in the PGM and cerebellum.
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CONCLUSIONS
We demonstrated that GSH measurement in nonsedated children is
feasible. We found higher GSH in the cerebellum compared with the
PGM. Differences in the other metabolites agree with published MRS
data in adults; this finding suggests no major metabolic maturation
effect from 7 years of age and older in our dataset.
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